Company Filing History:
Years Active: 1995-2002
Title: Michael R Brigham-Burke: Innovator in Tumor Necrosis Factor Research
Introduction
Michael R Brigham-Burke is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of tumor necrosis factor research, holding a total of 3 patents. His work focuses on identifying agonists and antagonists for tumor necrosis-related receptors, which has implications for cancer treatment.
Latest Patents
One of his latest patents is titled "Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2." This invention relates to tumor necrosis factor receptor (TNF-R) related polypeptides and their ligands, specifically TR1, TR2, TL2, and TL4. The methods developed in this patent aim to identify agonists and antagonists of these receptors, which could lead to advancements in therapeutic strategies.
Another significant patent is "Surface plasmon resonance detector having collector for eluted ligate." This improved surface plasmon resonance detector is capable of recovering a desired eluted ligate, allowing for the isolation and characterization of novel ligates and ligands. This innovation enhances the capabilities of researchers in the field.
Career Highlights
Michael R Brigham-Burke is currently associated with SmithKline Beecham Corporation, where he continues to contribute to research and development in his area of expertise. His work has been instrumental in advancing the understanding of tumor necrosis factors and their potential therapeutic applications.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Daniel J O'Shannessy and Peter R Young. These collaborations have further enriched his research and contributed to the success of his projects.
Conclusion
Michael R Brigham-Burke is a distinguished inventor whose work in tumor necrosis factor research has led to valuable patents and advancements in the field. His contributions continue to impact cancer research and treatment strategies.